ArticleOxford medical case reports2021

Transfusion-dependent anaemia treatment using continuous erythropoietin receptor activator (epoetin β pegol) and roxadustat after darbepoetin treatment failure in low-risk myelodysplastic syndrome: a case report.

Tatsuyoshi Ikenoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.